Pinnacle Associates Ltd. Has $1.84 Million Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Pinnacle Associates Ltd. grew its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,556 shares of the financial services provider’s stock after buying an additional 359 shares during the period. Pinnacle Associates Ltd.’s holdings in iShares Biotechnology ETF were worth $1,842,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Williams Financial LLC bought a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $867,000. PVG Asset Management Corp bought a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $415,000. Oppenheimer & Co. Inc. boosted its position in shares of iShares Biotechnology ETF by 7.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock valued at $4,905,000 after purchasing an additional 2,532 shares in the last quarter. PFG Advisors boosted its position in shares of iShares Biotechnology ETF by 3.9% during the 1st quarter. PFG Advisors now owns 4,655 shares of the financial services provider’s stock valued at $639,000 after purchasing an additional 173 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in shares of iShares Biotechnology ETF by 113.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 946 shares of the financial services provider’s stock valued at $130,000 after purchasing an additional 502 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.8 %

Shares of NASDAQ:IBB opened at $142.78 on Friday. The business’s 50 day simple moving average is $145.02 and its two-hundred day simple moving average is $140.37. iShares Biotechnology ETF has a 52-week low of $113.56 and a 52-week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.